WHO Warns of Parasite Evolution & Spread: Schistosomiasis Risks Rise Globally
- The World Health Organization (WHO) has raised concerns about evolving forms of schistosomiasis, a parasitic disease that affects millions globally.
- Schistosomiasis is contracted through contact with freshwater contaminated with the larvae of certain snail species.
- According to the WHO, the parasite is undergoing hybridization, combining genetic material from different strains.
The World Health Organization (WHO) has raised concerns about evolving forms of schistosomiasis, a parasitic disease that affects millions globally. Recent observations indicate changes in the behavior and spread of the parasite responsible for the disease, with some strains demonstrating an increased ability to survive in new regions. , the WHO highlighted the emergence of hybrid parasite forms, prompting a global alert.
Schistosomiasis is contracted through contact with freshwater contaminated with the larvae of certain snail species. These larvae penetrate the skin, leading to infection. The disease is prevalent in tropical and subtropical areas, particularly in communities lacking access to safe drinking water and adequate sanitation.
Hybridization and New Transmission Pathways
According to the WHO, the parasite is undergoing hybridization, combining genetic material from different strains. This process is resulting in new transmission pathways and an expanded geographic range. The hybrid form exhibits an enhanced capacity to survive and spread beyond its traditional areas of prevalence. This adaptation is particularly concerning as it complicates efforts to control the infection.
One of the most alarming aspects of this hybridization is the parasite’s ability to establish itself in the urinary or genital region. This can lead to discomfort, pain, and, in severe cases, an increased risk of cancer or even death. The WHO issued this warning in conjunction with World Neglected Tropical Diseases Day
, aiming to draw attention to diseases affecting over a billion people in the world’s poorest regions.
Geographic Spread and Global Risks
While Africa remains the most heavily affected continent, cases of schistosomiasis have been reported in 78 countries worldwide, including China, Venezuela and Indonesia. This broader distribution suggests the parasite is capable of spreading beyond the typical snail habitats and through means beyond simple water contact. The emergence of hybrid strains further exacerbates this risk.
Currently, at least 251.4 million people require preventive treatment for schistosomiasis, according to WHO estimates from . Preventive chemotherapy, involving large-scale treatment of at-risk populations, is currently implemented in 51 countries with moderate-to-high transmission rates.
Understanding Schistosomiasis: Infection and Progression
Schistosomiasis is caused by blood flukes (trematode worms) of the genus Schistosoma. Infection occurs when larval forms of the parasite, released by freshwater snails, penetrate the skin upon contact with infested water. Once inside the body, the larvae develop into adult worms, which reside in blood vessels. Female worms release eggs, some of which are excreted in feces or urine, continuing the parasite’s lifecycle. However, other eggs become trapped in body tissues, triggering an immune response and progressive organ damage.
The disease can be asymptomatic for extended periods, allowing for irreversible damage to accumulate. The liver, lungs, and reproductive system are particularly vulnerable to the effects of egg deposition and subsequent inflammation. The two major forms of the disease – intestinal and urogenital – are caused by five main species of blood fluke.
Treatment and Emerging Challenges
Early detection and treatment with appropriate medications are crucial for managing schistosomiasis. However, emerging evidence suggests that the new hybrid strains may exhibit resistance to existing treatments, raising concerns among scientists. This potential for drug resistance underscores the need for continued research and development of new therapeutic strategies.
Research led by the Liverpool School of Tropical Medicine (LSTM) has also highlighted the threat posed by these hybrid parasites. Their findings, published in , emphasize the urgent need to understand the evolutionary changes occurring within the parasite population and to develop effective control measures.
The WHO’s warning serves as a critical reminder of the ongoing challenges posed by neglected tropical diseases. Addressing these challenges requires a concerted global effort, including improved access to safe water and sanitation, widespread preventive treatment programs, and continued investment in research and development.
While the situation is concerning, experts emphasize that increased awareness and proactive public health measures can mitigate the spread of schistosomiasis and protect vulnerable populations. Continued surveillance and monitoring of parasite evolution are essential to inform effective prevention and control strategies.